UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000055790 |
|---|---|
| Receipt number | R000063758 |
| Scientific Title | Effects of immersive virtual reality mobility slit training on patients with unilateral spatial neglect -A Randomized Controlled Trial- |
| Date of disclosure of the study information | 2024/10/10 |
| Last modified on | 2024/10/09 02:18:48 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effects of immersive virtual reality mobility slit training on patients with unilateral spatial neglect -A Randomized Controlled Trial-
Acronym
Effects of immersive virtual reality mobility slit training on patients with unilateral spatial neglect -A Randomized Controlled Trial-
Scientific Title
Effects of immersive virtual reality mobility slit training on patients with unilateral spatial neglect -A Randomized Controlled Trial-
Scientific Title:Acronym
Effects of immersive virtual reality mobility slit training on patients with unilateral spatial neglect -A Randomized Controlled Trial-
Region
| Japan |
Condition
Condition
Unilateral spatial neglect in stroke patients.
Classification by specialty
| Rehabilitation medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Effectiveness of immersive virtual reality mobility slit training on patients with unilateral spatial neglect
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Line cancellation, Line bisection, star cancellation and letter cancellation task.
Time of assessment:immediately before the in tervention and immediately after the intervention
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
3
Purpose of intervention
Treatment
Type of intervention
| Device,equipment |
Interventions/Control_1
Patients were attached a Head-mounted display (HMD) and presented three-dimensional Virtual reality space where multiple objects were installed. First, they answer aloud the objects'name of far space in three-dimensional Virtual reality space with HMD. Second, they touch the objects of near space with one hand hat is synchronized their hand of real in three-dimensional Virtual reality space with HMD. At this time, they are promoted attentional disengagement from the ipsilesional stimuli by blocking visual stimuli to direct attention and attentional movement from the ipsilesional to the contralesional side by expanding the visible area to contralesional side. They took about 30 minutes.
Interventions/Control_2
Patients were seated at a desk. They conducted visual scanning training on the screen. The screen is installed in front of the patient. The task of the patients is to answer the objects' name that is pointed by therapist. The objects were installed on the screen. They took about 6 minutes.
Interventions/Control_3
Patients were attached a Head-mounted display (HMD) and presented three-dimensional Virtual reality space where multiple objects were installed. They answer aloud the objects' name of far space in three-dimensional Virtual reality space with HMD. At this time patients attention is inducted to neglect side of a object. They took about 13 minutes.
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 85 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
(1)Imaging findings show foci in the right cerebral hemisphere.
(2)Patients who have neglected symptoms in the linear bisection test.
(3)Patients who have a reduced score on the Catherine Bergego Scale (hereinafter referred to as CBS) observation method.
(4)Patients who have had the disease for more than 1 month since the onset.
Key exclusion criteria
(1)Patients with homonymous hemianopia
(2)Those with difficulty in evaluation due to significant vision loss.
(3)Patients with complaints of mood discomfort due to VR sickness
(4)Those who could not give consent for the study.
(5)Patients who have difficulty in following the subject due to oculomotor paralysis
Target sample size
54
Research contact person
Name of lead principal investigator
| 1st name | Hiroyasu |
| Middle name | |
| Last name | Iwata |
Organization
Waseda University
Division name
Faculty science and engineering
Zip code
162-0042
Address
27 Waseda-cyomachi, Shinjuku-ku, Tokyo, Japan Green Computing Systems Reserch Organization 603 Prof. Iwata Lab.
TEL
03-3203-4427
jubi@waseda.jp
Public contact
Name of contact person
| 1st name | Hiroyasu |
| Middle name | |
| Last name | Iwata |
Organization
Waseda University
Division name
Faculty science and engineering
Zip code
162-0042
Address
27 Waseda-cyomachi, Shinjuku-ku, Tokyo, Japan Green Computing Systems Reserch Organization 603
TEL
03-3203-4427
Homepage URL
jubi@waseda.jp
Sponsor or person
Institute
Wasada University
Institute
Department
Personal name
Funding Source
Organization
Waseda University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Wasada University ethics review committee
Address
The 9th Building, 2nd Floor, 1-104 Totsuka-machi, Shinjuku-ku, Tokyo
Tel
03-5272-1639
rinri@list.waseda.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
苑田会リハビリテーション病院（東京都）、花はたリハビリテーション病院（東京都）、医療法人社団健育会ねりま健育会病院（東京都）、福岡リハビリテーション病院（福岡県）
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 10 | Month | 10 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2024 | Year | 10 | Month | 10 | Day |
Date of IRB
Anticipated trial start date
| 2024 | Year | 11 | Month | 01 | Day |
Last follow-up date
| 2029 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2024 | Year | 10 | Month | 09 | Day |
Last modified on
| 2024 | Year | 10 | Month | 09 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063758
